Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-126957)

Filing Details

Accession Number:: 0001104659-20-126957
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-18 18:16:31
Reporting Period:: 2020-11-16

Accepted Time:: 2020-11-18 18:16:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727510	Enzon Pharmaceuticals Inc.	ENZN	Biological Products, (No Disgnostic Substances) (2836)	222372868

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1074613	C Randolph Read	C/O Enzon Pharmaceuticals, Inc. 20 Commerce Drive (Suite 135) Cranford NJ 07016		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-16	50,450	$0.15	50,450	No	4	P	Direct
Common Stock	Acquisiton	2020-11-18	50,000	$0.16	100,450	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Represents the weighted average purchase price of multiple transactions, with shares purchased at prices ranging from $0.1502 to $0.1511 per share. The reporting person hereby undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the issuer or a stockholder of the issuer, full information regarding the number of shares purchased at each separate price.